Imogen Mansfield
Stock Analyst at Cantor Fitzgerald
(0.82)
# 4,081
Out of 5,060 analysts
11
Total ratings
11.1%
Success rate
-8.9%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Imogen Mansfield
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SLGL Sol-Gel Technologies | Initiated Coverage: Buy | $200 | $64.25 | +211.28% | 1 | Oct 14, 2026 | |
| OVID Ovid Therapeutics | Initiated Coverage: Buy | $6 | $2.15 | +179.07% | 1 | Oct 9, 2026 | |
| ENTX Entera Bio | Initiated Coverage: Buy | n/a | $2.68 | - | 1 | Sep 22, 2026 | |
| LHX L3Harris Technologies | Reiterated: Buy | $384 | $248.51 | +54.52% | 1 | May 19, 2026 | |
| RBC RBC Bearings | Reiterated: Buy | $615 | $498.52 | +23.37% | 1 | May 19, 2026 | |
| QTTB Q32 Bio | Initiated Coverage: Buy | n/a | $7.52 | - | 1 | May 18, 2026 | |
| SARO StandardAero | Reiterated: Buy | $35 | $21.31 | +64.24% | 3 | May 18, 2026 | |
| VSEC VSE Corporation | Reiterated: Buy | $270 | $164.08 | +64.55% | 1 | May 14, 2026 | |
| BWXT BWX Technologies | Reiterated: Hold | $212 | $137.01 | +54.73% | 1 | May 11, 2026 |
Sol-Gel Technologies
Oct 14, 2026
Initiated Coverage: Buy
Price Target: $200
Current: $64.25
Upside: +211.28%
Ovid Therapeutics
Oct 9, 2026
Initiated Coverage: Buy
Price Target: $6
Current: $2.15
Upside: +179.07%
Entera Bio
Sep 22, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $2.68
Upside: -
L3Harris Technologies
May 19, 2026
Reiterated: Buy
Price Target: $384
Current: $248.51
Upside: +54.52%
RBC Bearings
May 19, 2026
Reiterated: Buy
Price Target: $615
Current: $498.52
Upside: +23.37%
Q32 Bio
May 18, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $7.52
Upside: -
StandardAero
May 18, 2026
Reiterated: Buy
Price Target: $35
Current: $21.31
Upside: +64.24%
VSE Corporation
May 14, 2026
Reiterated: Buy
Price Target: $270
Current: $164.08
Upside: +64.55%
BWX Technologies
May 11, 2026
Reiterated: Hold
Price Target: $212
Current: $137.01
Upside: +54.73%